Atreca, Inc.
BCELDelisted Mar 20, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001532346
Atreca, Inc. was delisted on Mar 20, 2024; its insiders filed their last Form 4 on Apr 17, 2024; 43 institutions reported holding it in 13F filings for Q4 2023, worth $1.24M in total; no superinvestor held it.
Members of Congress who traded BCEL
Since 2020, newest trade first. Options and trades reported under an earlier ticker are included.
- Trades
- 2
- Filings
- 2
- Members
- 1
- Buys / sells
- 1 / 1
- Estimated volume
- $40.5K
- Sum of range midpoints
| Member | Trades | Buys / sells | Est. volume | Last traded | Last filed |
|---|---|---|---|---|---|
| Chris JacobsRepublican · House · NY | 2 | 1 / 1 | $40.5K | Nov 8, 2022 | Dec 12, 2022 |
Trades
Every reported trade in Atreca, Inc., newest filings first.
| Member | Asset | Type | Owner | Traded | Filed | Delay | Amount | Source |
|---|---|---|---|---|---|---|---|---|
| Chris JacobsRepublican · House · NY | BCELAtreca, Inc. - Class A | Sell | Self | Nov 8, 2022 | Dec 12, 2022 | 34 days | $1K-$15K | Filing |
| Chris JacobsRepublican · House · NY | BCELAtreca, Inc. - Class A | Buy | Self | Jun 16, 2022 | Jul 28, 2022 | 42 days | $15K-$50K | Filing |
Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.